TopPodcast.com
Menu
  • Home
  • Top Charts
  • Top Networks
  • Top Apps
  • Top Independents
  • Top Podfluencers
  • Top Picks
    • Top Business Podcasts
    • Top True Crime Podcasts
    • Top Finance Podcasts
    • Top Comedy Podcasts
    • Top Music Podcasts
    • Top Womens Podcasts
    • Top Kids Podcasts
    • Top Sports Podcasts
    • Top News Podcasts
    • Top Tech Podcasts
    • Top Crypto Podcasts
    • Top Entrepreneurial Podcasts
    • Top Fantasy Sports Podcasts
    • Top Political Podcasts
    • Top Science Podcasts
    • Top Self Help Podcasts
    • Top Sports Betting Podcasts
    • Top Stocks Podcasts
  • Podcast News
  • About Us
  • Podcast Advertising
  • Contact
Not in our directory?
Add Show Here
Podcast Equipment
Center

toppodcastlogoOur TOPPODCAST Picks

  • Comedy
  • Crypto
  • Sports
  • News
  • Politics
  • True Crime
  • Business
  • Finance

Follow Us

toppodcastlogoStay Connected

    View Top 200 Chart
    Back to Rankings Page
    Health & Fitness

    Coronavirus (COVID-19) Q&A

    Conversations with experts and frontline clinicians about the COVID-19 pandemic, hosted by editors from the JAMA Network.

    Advertise
    • Apple Podcasts
    • Google Play
    • Spotify
    Latest Episodes:
    Coronavirus Variants With John P. Moore Mar 08, 2021
    Show notes

    Genetic variants of the SARS-CoV-2 virus are emerging but so far do not seem to have caused breakthrough infections in people with previous infection or in those who have been vaccinated. John P. Moore, PhD, of Weill Medical College of Cornell University in New York, joins JAMA's Q&A series for an update on the latest variants and what you need to know. Recorded March 4, 2021.

    Related Article:

    Approaches for Optimal Use of Different COVID-19 Vaccines

    Will COVID-19 Become a Recurrent Seasonal Disease? Mar 03, 2021
    Show notes

    Interview with Christopher J.L. Murray, MD, DPhil, author of The Potential Future of the COVID-19 Pandemic: Will SARS-CoV-2 Become a Recurrent Seasonal Infection?

    Related Article(s):

    The Potential Future of the COVID-19 Pandemic

    Funding of Pharmaceutical Innovation During and After the COVID-19 Pandemic Mar 02, 2021
    Show notes

    Interview with James C. Robinson, PhD, author of Funding of Pharmaceutical Innovation During and After the COVID-19 Pandemic

    Coronavirus Vaccine Update From the CDC With Nancy E. Messonnier, MD Mar 02, 2021
    Show notes

    Nancy E. Messonnier, MD is director of the National Center for Immunization and Respiratory Diseases (NCIRD) at the Centers for Disease Control and Prevention (CDC) and leads the CDC's efforts on COVID-19 vaccination. She joins JAMA's Q&A series to discuss the agency's response to emerging coronavirus variants, the FDA advisory hearings on the new Johnson & Johnson vaccine, and other agency activities and priorities related to COVID-19 control. Recorded February 26, 2021.

    Related Content:

    • Genetic Variants of SARS-CoV-2—What Do They Mean?
    • Coronavirus Vaccine Update From the CDC With Nancy E. Messonnier, MD
    • SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants
    • Experts Discuss COVID-19—Vaccine Doses, Virus Variants, and More
    • Emergence of a Novel SARS-CoV-2 Variant in Southern California
    • SARS-CoV-2 Variants of Concern in the United States
    • Pregnant People Getting Mixed Messages About COVID-19 Vaccines
    • The Johnson & Johnson Vaccine for COVID-19
    • SARS-CoV-2 Viral Variants—Tackling a Moving Target
    • Vaccine Distribution—Equity Left Behind?
    • Taking Vaccine to Where the Virus Is—Equity and Effectiveness in Coronavirus Vaccinations?
    Coronavirus Vaccines—An Overview Feb 26, 2021
    Show notes

    The Pfizer-BioNTech and Moderna COVID-19 mRNA vaccines are the first of many being tested for widespread use. Buddy Creech, MD, MPH, director of the Vanderbilt Vaccine Research Program, reviews these and other vaccines likely to become available, including products that use inactivated, protein subunit, and viral vector immunization strategies.

    Related Article(s):

    SARS-CoV-2 Vaccines

    Vaccinating Nursing Home and Long-term Care Facility Residents for Coronavirus Feb 24, 2021
    Show notes

    The CDC coordinated a massive effort to immunize nearly all nursing home and long-term care facility residents in the US against COVID-19 infection in the month after vaccine approval. Ruth Link-Gelles, PhD, MPH, CDC staff epidemiologist and Lieutenant Commander of the US Public Health Service Commissioned Corps, describes how.

    Related Article(s):

    • First-Dose COVID-19 Vaccination Coverage Among Skilled Nursing Facility Residents and Staff
    • Nursing Homes' Next Test—Vaccinating Workers Against COVID-19
    February 2021 Medical News Summary Feb 23, 2021
    Show notes

    Researchers Investigate What COVID-19 Does to the Heart; "Important Conversations" Are Needed to Explain the Nocebo Effect; Therapists Donate Their Time to Counsel Distressed Health Care Workers

    Related Article:

    Researchers Investigate What COVID-19 Does to the Heart

    "Important Conversations" Are Needed to Explain the Nocebo Effect

    Therapists Donate Their Time to Counsel Distressed Health Care Workers

    Coronavirus Update With CDC Director Rochelle Walensky - February 17, 2021 Feb 19, 2021
    Show notes

    CDC Director Rochelle P. Walensky, MD, MPH, returns to JAMA's Q&A series to discuss the agency's response to emerging SARS-CoV-2 variants, implications for the planned vaccine mobilization strategy, the upcoming Johnson & Johnson vaccine FDA advisory hearings, strategies for reopening K-12 schools, and other agency activities and priorities related to COVID-19 control. Recorded February 17, 2021.

    Related Article(s):

    • Coronavirus Update With CDC Director Rochelle Walensky - February 17, 2021
    • SARS-CoV-2 Variants of Concern in the United States—Challenges and Opportunities
    • SARS-CoV-2 Viral Variants—Tackling a Moving Target
    Coronavirus Vaccine Update With Paul Offit – February 11, 2021 Feb 15, 2021
    Show notes

    Paul A. Offit, MD, of The Children's Hospital of Philadelphia returns to JAMA's Q&A series to provide an update on the emergence of COVID-19 variants and their implications for vaccine development, including the Johnson & Johnson vaccine, scheduled for a US Food and Drug Administration VRBPAC hearing on February 26, 2021. Recorded February 11, 2021.

    Related Article:

    SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants

    Mask Wearing for COVID-19 Prevention—Summary of CDC Data Feb 10, 2021
    Show notes

    Natural experiments comparing coronavirus spread on ships and in hair salons with vs without face masks point to the importance of wearing masks for curbing SARS-CoV-2 spread. John T. Brooks, MD, chief medical officer of the CDC's COVID-19 response team, reviews recently published epidemiologic data that reinforce the role of mask use for pandemic control.

    Related Article:

    Effectiveness of Mask Wearing to Control Community Spread of SARS-CoV-2

    Previous 1 4 5 6 7 8 23 Next

    Related Podcasts

    Fresh Air

    1

    Fresh Air Arts
    Twenty Thousand Hertz

    2

    Twenty Thousand Hertz Arts
    The Black Tapes

    3

    The Black Tapes Arts
    Snap Judgment

    4

    Snap Judgment Arts
    Here’s The Thing with Alec Baldwin

    5

    Here’s The Thing with Alec Baldwin Arts
    The NoSleep Podcast – Creative Reason Media Inc.

    6

    The NoSleep Podcast – Creative Reason Media Inc. Arts
    footer-logo

    Contact Us

    Toll Free: 844-670-7747

    Links

    • Home
    • Top Charts
    • Networks
    • Apps
    • Independents Podcasts
    • Podcast Advertising
    • Podcast News
    • Contact Us
    • About Us
    • Analytics & Insights

    Stay Connected

      Privacy, Terms of Use & Our Code of Ethics Protecting Content Creators Copyrights